Please use this identifier to cite or link to this item: https://doi.org/10.1002/dmrr.1005
DC FieldValue
dc.titleBaicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats
dc.contributor.authorWaisundara, V.Y.
dc.contributor.authorHsu, A.
dc.contributor.authorTan, B.K.-H.
dc.contributor.authorHuang, D.
dc.date.accessioned2014-06-23T05:32:49Z
dc.date.available2014-06-23T05:32:49Z
dc.date.issued2009-10
dc.identifier.citationWaisundara, V.Y., Hsu, A., Tan, B.K.-H., Huang, D. (2009-10). Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats. Diabetes/Metabolism Research and Reviews 25 (7) : 671-677. ScholarBank@NUS Repository. https://doi.org/10.1002/dmrr.1005
dc.identifier.issn15207552
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/75640
dc.description.abstractBackground: Hyperglycemia-induced superoxide production in the mitochondria is known to be the primary cause of diabetic micro- and macro-vascular complications and mitochondrial membranal damage. This study in streptozotocin-induced diabetic Wistar rats investigated the anti-hyperglycemic and mitochondrial membrane protection effects of baicalin, a flavonoid known for its radical scavenging activity. Methods: The following oral treatments were given to diabetic rats for 30 days: (1) metformin 500 mg/kg, (2) baicalin 120 mg/kg, and (3) metformin 500 mg/kg & baicalin 120 mg/kg, with vehicle-treated diabetic and non-diabetic groups serving as controls. Results: Transmission electron microscopy imaging of pancreatic β-cells revealed loss of integrity of the inner membrane of the mitochondria in the diabetic rats, which was not observed in the baicalin-treated group. In addition, baicalin and the combined treatment of metformin and baicalin had significantly reduced (p < 0.05) the number of mitochondria with a damaged membrane compared to the diabetic control as well as the metformin-treated group in the hepatic tissues. Baicalin had also increased the plasma leptin content (p < 0.05) versus the diabetic control, which in turn had effected the total expression of hepatic mitochondria per cell indicating its effects in SIRT1 activity. The increase in mitochondrial number was further complemented with similar trends in the hepatic citrate synthase activity. Conclusions: Baicalin had reduced the hyperglycemia-induced mitochondrial membrane damage, as well as enhanced the effects of metformin, as was observed in the results from the metformin and baicalin treated groups. Copyright © 2009 John Wiley & Sons, Ltd.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1002/dmrr.1005
dc.sourceScopus
dc.subjectBaicalin
dc.subjectHyperglycemia
dc.subjectMitochondria
dc.subjectWistar rats
dc.typeArticle
dc.contributor.departmentCHEMISTRY
dc.description.doi10.1002/dmrr.1005
dc.description.sourcetitleDiabetes/Metabolism Research and Reviews
dc.description.volume25
dc.description.issue7
dc.description.page671-677
dc.description.codenDMRRF
dc.identifier.isiut000270856700010
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

36
checked on Oct 11, 2019

WEB OF SCIENCETM
Citations

33
checked on Oct 11, 2019

Page view(s)

54
checked on Oct 13, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.